Loading clinical trials...

Cryo-Touch II for the Treatment of Wrinkles | Clinical Trials | Clareo Health

COMPLETEDPHASE2/PHASE3

Cryo-Touch II for the Treatment of Wrinkles

NCT01167140•Pacira Pharmaceuticals, Inc

Summary

This is a prospective, non-randomized study to evaluate the performance of the MyoScience Cryo-Touch II device for the treatment of wrinkles.

Eligibility

Age

30 - 70 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Age 30-70 years
•Subject has a glabellar and/or forehead wrinkle rating by investigator of at least 1 at rest on the 5-point Wrinkle Scale (5WS)\*
•Subject has signed IRB-approved informed consent form

Exclusion Criteria

•Subject takes any medication or dietary supplement regularly that affects blood clotting (e.g., Coumadin, aspirin, clopidogrel) or increases the risk of bleeding/bruising
•Subject has had prior surgery that alters the subcutaneous anatomy of the target treatment sites
•The investigator is unable to substantially lessen facial lines by physical separation
•Subject has undergone another facial cosmetic procedures at or above the level of the cheekbones within the past 6 months
•Subject is participating in another facial cosmetic research study
•Patient has any of following conditions:
•History of facial nerve palsy
•Marked facial asymmetry
•Ptosis
•Excessive dermatochalasis
+5 more criteria

Locations (1)

The Aesthetics Research Center

Redwood City, California, United States

Key Dates

Start Date

July 1, 2010

Primary Completion Date

January 1, 2011

Completion Date

April 1, 2011

Last Updated

January 24, 2024

Enrollment

ACTUAL participants

Conditions

Facial Wrinkles

Interventions

Cryo-Touch II

DEVICE

Safety and Efficacy Evaluation of the Monopolar Radiofrequency Device for the Improvement of Facial Wrinkles

NCT06657365

Facial WrinklesAnti-Aging+3 more

View study

COMPLETEDNA

The Use of J-Plasma® for Dermal Resurfacing

NCT03286283

Facial WrinklesRhytides

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 24, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Cryo-Touch II for the Treatment of Wrinkles

Inclusion Criteria

Exclusion Criteria

Safety and Efficacy Evaluation of the Monopolar Radiofrequency Device for the Improvement of Facial Wrinkles

The Use of J-Plasma® for Dermal Resurfacing

Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers

A Study to Compare the Safety and Effectiveness of a Non-FDA Approved Device Dermal Gel Extra (DGE) and an FDA Approved Device for the Correction of Nasolabial Folds (NLFs)

A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)

Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults